Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05462639
Title Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma (MAGNETISMM17)
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Pfizer
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.